CRISPR/Cas9 and targeted cancer therapy

Medicine and Dentistry

• Cancer Cell 10%
• Cancer Therapy 40%
• Cas9 100%
• Clustered Regularly Interspaced Short Palindromic Repeat 100%
• Drug Resistance 10%
• Enhancer Region 10%
• Epidermal Growth Factor Receptor 10%
• Malignant Neoplasm 10%
• Molecularly Targeted Therapy 100%
• Nuclease 10%
• Receptor Family 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Drug Resistance 14%
• Epidermal Growth Factor Receptor 14%
• Malignant Neoplasm 100%
• Nuclease 14%

Keyphrases

• Cas9 Activity 9%
• Cas9 Inhibitor 9%
• CXCR7 9%